Antibiotic Resistant Sepsis Pathogens

Please register and login for full functionality including access to datasets.

The Antibiotic Resistant Sepsis Pathogens Framework Data Initiative aims to develop a framework dataset that will enable identification of core targets common to sepsis pathogens using a multi-omics approach (genomics, transcriptomics, proteomics, metabolomics).

Five clinical strains of Escherichia coli, Klebsiella pneumoniae, Streptococcus pneumoniae, Staphylococcus aureus and Streptococcus pyogenes selected by members of the consortium will form the core of the project.

For more information, please visit:

Project Pages

Invitation to Collaborate

Bioplatforms Australia promotes data sharing and collaborative interactions are encouraged to advance scientific discovery and maximize the value to the community from this Australian Government (NCRIS)-funded dataset. As such, the consortium would like to extend an invitation to collaborate.

Data from the Initiative is made available to members of the consortium upon generation. Following a period of mediated access, where access to the data will be limited to members of the consortium and other approved parties, the data will be made available publicly.

Should you wish to access the data during this mediated period, please email ( with your name, affiliation, specific data for which access is being requested and a brief outline of the intended data use. This information will be assessed by Bioplatforms Australia and the consortium, and you will be contacted to discuss collaborative access.

Please find the Data Release Policy here (

Acknowledging the consortium

When using Antibiotic Resistant Sepsis Pathogens Framework Initiative data, please acknowledge the Consortium and Bioplatforms Australia support using the following wording:

"We would like to acknowledge the contribution of the Antibiotic Resistant Sepsis Pathogens Framework Initiative consortium ( in the generation of data used in this publication. The Initiative is supported by funding from Bioplatforms Australia through the Australian Government National Collaborative Research Infrastructure Strategy (NCRIS)."